Despoina Koulenti

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Venues

Antibiotics (Basel, Switzerland)

Microorganisms

Future microbiology

Critical care (London, England)

National and Kapodistrian University of Athens: Athens, Greece (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

National and Kapodistrian University of Athens: Athens, Greece

Greece

PHD :: School of Medicine

Publications

Despoina Koulenti, Elizabeth Paramythiotou, Maria Panagiota Almyroudi, Marios Karvouniaris, Nikolaos Markou, Paschalis Paranos, Christina Routsi, Joseph Meletiadis, Stijn I Blot
Severe mold fungal infections in critically ill patients with COVID-19. Future microbiology 19 (9) (2024)
Despoina Koulenti, Elizabeth Paramythiotou, Maria Panagiota Almyroudi, Marios Karvouniaris, Nikolaos Markou, Paschalis Paranos, Christina Routsi, Joseph Meletiadis, Stijn I Blot
Severe mold fungal infections in critically ill patients with COVID-19. Future microbiology 19 (9) (2024)
Despoina Koulenti, Elizabeth Paramythiotou, Maria Panagiota Almyroudi, Marios Karvouniaris, Nikolaos Markou, Paschalis Paranos, Christina Routsi, Joseph Meletiadis, Stijn I Blot
Severe mold fungal infections in critically ill patients with COVID-19. Future microbiology (2024)
Ioannis Andrianopoulos, Nikolaos Kazakos, Nikolaos Lagos, Theodora Maniatopoulou, Athanasios Papathanasiou, Georgios Papathanakos, Despoina Koulenti, Eleni Toli, Konstantina Gartzonika, Vasilios Koulouras
Co-Administration of High-Dose Nebulized Colistin for Acinetobacter baumannii Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes. Antibiotics (Basel, Switzerland) 13 (2) (2024)
Ioannis Andrianopoulos, Nikolaos Kazakos, Nikolaos Lagos, Theodora Maniatopoulou, Athanasios Papathanasiou, Georgios Papathanakos, Despoina Koulenti, Eleni Toli, Konstantina Gartzonika, Vasilios Koulouras
Co-Administration of High-Dose Nebulized Colistin for Acinetobacter baumannii Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes. Antibiotics (Basel, Switzerland) 13 (2) (2024)
Despoina Koulenti, Elizabeth Paramythiotou, Maria Panagiota Almyroudi, Marios Karvouniaris, Nikolaos Markou, Paschalis Paranos, Christina Routsi, Joseph Meletiadis, Stijn I Blot
Severe mold fungal infections in critically ill patients with COVID-19. Future microbiology 19 (9) (2024)
Ioannis Andrianopoulos, Nikolaos Kazakos, Nikolaos Lagos, Theodora Maniatopoulou, Athanasios Papathanasiou, Georgios Papathanakos, Despoina Koulenti, Eleni Toli, Konstantina Gartzonika, Vasilios Koulouras
Co-Administration of High-Dose Nebulized Colistin for Acinetobacter baumannii Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes. Antibiotics (Basel, Switzerland) 13 (2) (2024)
Dalia Adukauskiene, Ausra Ciginskiene, Agne Adukauskaite, Despoina Koulenti, Jordi Rello
Clinical Features and Outcomes of VAP Due to Multidrug-Resistant Klebsiella spp.: A Retrospective Study Comparing Monobacterial and Polybacterial Episodes. Antibiotics (Basel, Switzerland) 12 (6) (2023)
Dalia Adukauskiene, Ausra Ciginskiene, Agne Adukauskaite, Despoina Koulenti, Jordi Rello
Clinical Features and Outcomes of VAP Due to Multidrug-Resistant Klebsiella spp.: A Retrospective Study Comparing Monobacterial and Polybacterial Episodes. Antibiotics (Basel, Switzerland) 12 (6) (2023)
Georgios Papathanakos, Ioannis Andrianopoulos, Menelaos Xenikakis, Athanasios Papathanasiou, Despoina Koulenti, Stijn I Blot, Vasilios Koulouras
Clinical Sepsis Phenotypes in Critically Ill Patients. Microorganisms 11 (9) (2023)
Ioannis Andrianopoulos, Theodora Maniatopoulou, Nikolaos Lagos, Nikolaos Kazakos, Athanasios Papathanasiou, Georgios Papathanakos, Despoina Koulenti, Christos Kittas, Vasilios Koulouras
Acinetobacter baumannii Bloodstream Infections in the COVID-19 Era: A Comparative Analysis between COVID-19 and Non-COVID-19 Critically Ill Patients. Microorganisms 11 (7) (2023)
Marios Karvouniaris, Maria Panagiota Almyroudi, Mohd Hafiz Abdul-Aziz, Stijn Blot, Elizabeth Paramythiotou, Evdoxia Tsigou, Despoina Koulenti
Novel Antimicrobial Agents for Gram-Negative Pathogens. Antibiotics (Basel, Switzerland) 12 (4) (2023)
Marios Karvouniaris, Maria Panagiota Almyroudi, Mohd Hafiz Abdul-Aziz, Stijn Blot, Elizabeth Paramythiotou, Evdoxia Tsigou, Despoina Koulenti
Novel Antimicrobial Agents for Gram-Negative Pathogens. Antibiotics (Basel, Switzerland) 12 (4) (2023)
Christina Routsi, Joseph Meletiadis, Efstratia Charitidou, Aikaterini Gkoufa, Stelios Kokkoris, Stavros Karageorgiou, Charalampos Giannopoulos, Despoina Koulenti, Petros Andrikogiannopoulos, Efstathia Perivolioti, Athina Argyropoulou, Ioannis Vasileiadis, Georgia Vrioni, Elizabeth Paramythiotou
Epidemiology of Candidemia and Fluconazole Resistance in an ICU before and during the COVID-19 Pandemic Era. Antibiotics (Basel, Switzerland) 11 (6) (2022)
Marios Karvouniaris, Alexandros G Brotis, Konstantinos Tsiakos, Eleni Palli, Despoina Koulenti
Current Perspectives on the Diagnosis and Management of Healthcare-Associated Ventriculitis and Meningitis. Infection and drug resistance 15 (2022)
Andrew Conway Morris, Katharina Kohler, Thomas De Corte, Ari Ercole, Harm-Jan S de Grooth, Paul W G Elbers, Paula Fernandes, Rui Morais, Despoina Koulenti, Sameer Jog, Nathan D Nielsen, Alasdair Jubb, Maurizio Cecconi, Jan J De Waele, null null
Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set. Critical care (London, England) 26 (1) (2022)
Andrew Conway Morris, Katharina Kohler, Thomas De Corte, Ari Ercole, Harm-Jan S de Grooth, Paul W G Elbers, Paula Fernandes, Rui Morais, Despoina Koulenti, Sameer Jog, Nathan D Nielsen, Alasdair Jubb, Maurizio Cecconi, Jan J De Waele, null null
Correction: Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set. Critical care (London, England) 26 (1) (2022)
Elena Xu, David Pérez-Torres, Paraskevi C Fragkou, Jean-Ralph Zahar, Despoina Koulenti
Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management. Microorganisms 9 (3) (2021)
Despoina Koulenti, Paraskevi C Fragkou, Sotirios Tsiodras
Editorial for Special Issue "Multidrug-Resistant Pathogens". Microorganisms 8 (9) (2020)
Georgios Papathanakos, Ioannis Andrianopoulos, Athanasios Papathanasiou, Efthalia Priavali, Despoina Koulenti, Vasilios Koulouras
Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients. Microorganisms 8 (2) (2020)
Despoina Koulenti, Kostoula Arvaniti, Mathew Judd, Natasha Lalos, Iona Tjoeng, Elena Xu, Apostolos Armaganidis, Jeffrey Lipman
Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat? Antibiotics (Basel, Switzerland) 9 (2) (2020)
Despoina Koulenti, Elena Xu, Isaac Yin Sum Mok, Andrew Song, Drosos E Karageorgopoulos, Apostolos Armaganidis, Jeffrey Lipman, Sotirios Tsiodras
Lefamulin. Comment on: "Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms. Microorganisms, 2019, 7, 270". Microorganisms 7 (10) (2019)

Despoina Koulenti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Despoina Koulenti